Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Dysregulation of Retinoic Acid Signaling in Stem Cells Spurs Tumor Growth

By LabMedica International staff writers
Posted on 05 Nov 2018
A team of cancer researchers identified the retinoic acid molecular signaling pathway as being a factor that helps to prevent the development of colorectal cancer.

Investigators at the Christiana Care Health System (Wilmington, DE, USA) were studying the factors controlling the differentiation of colon cancer stem cells (SCs) into undifferentiated tumor cells or, in some cases, into differentiated (non-cancerous) colon cells. More...
Since tumor development is driven by stem cell overpopulation, and in light of earlier findings that the enzyme aldehyde dehydrogenase (ALDH) was both a marker for SCs in many tissues and a key enzyme in retinoid acid (RA) signaling, the investigators examined RA signaling in normal and malignant colonic SCs.

The investigators analyzed normal and malignant colonic tissues and colorectal cancer (CRC) cell lines to see if retinoid receptors (RXR & RAR) were exclusively expressed in ALDH+ SCs, and if RA signaling changed during CRC development. Specifically, they determined whether RA signaling regulated cancer SC proliferation, differentiation, sphere formation, and population size.

Results published in the October 5, 2018, online edition of the journal Oncotarget revealed that RXR & RAR were expressed in ALDH+ colonic SCs, but not in normal cells. Western blotting/immunostaining of CRCs revealed that RA signaling components became overexpressed in parallel with ALDH overexpression, which coincided with the known overpopulation of ALDH+ SCs that occurs during, and drives, CRC development.

Treatment of SCs with all-trans retinoic acid (ATRA) was found to decrease proliferation, sphere formation, and ALDH+ SC population size and to induce differentiation. Thus, dysregulation of RA signaling in colonic SCs likely contributed to overpopulation of ALDH+ SCs and CRC growth.

“Our findings point to a number of possibilities for developing more effective stem cell targeting therapies for advanced colorectal cancer,” said senior author Dr. Bruce Boman, a senior research scientist at the Christiana Care Health System. “Our thinking has shifted to the insight that cancers originate in tissue stem cells through dysregulation or malfunction of the self-renewal process, and that cancer stem cells drive tumor growth. It follows that the optimal way to treat cancer (especially advanced cancer) is to eliminate cancer stem cells. We discovered that the retinoic acid or RA signaling pathway acts to induce differentiation of colon cancer stem cells and reduce cancer stem cell overpopulation, which puts the brakes on the primary mechanism that drives colon cancer development.”

Related Links:
Christiana Care Health System


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.